Approval Timelines for Advanced Therapeutics in Inflammatory Bowel Disease: A Comparison Between the European Medicines Agency and the Food and Drug Administration.

Autor: Hanzel J; Department of Gastroenterology and Hepatology, University Medical Center Ljubljana, University of Ljubljana, Ljubljana, Slovenia.; Alimentiv Inc, London, ON, Canada., Ma C; Department of Community Health Sciences, University of Calgary, Calgary, AB, Canada.; Alimentiv Inc, London, ON, Canada.; Division of Gastroenterology & Hepatology, Department of Medicine, University of Calgary, Calgary, AB, Canada., De Silva TA; Schulich School of Medicine and Dentistry, Western University, London, ON, Canada., Alphonsus L; Schulich School of Medicine and Dentistry, Western University, London, ON, Canada., Guizzetti L; Independent statistical consultant, London, ON, Canada., Crowley E; Division of Pediatric Gastroenterology and Hepatology, Department of Pediatrics, Children's Hospital Western Ontario, Western University, London, ON, Canada.; Alimentiv Inc, London, ON, Canada., Singh S; Division of Gastroenterology, University of California San Diego, La Jolla, CA, USA., Jairath V; Department of Epidemiology and Biostatistics, Western University, London, ON, Canada.; Alimentiv Inc, London, ON, Canada.; Division of Gastroenterology, Department of Medicine, Western University, London, ON, Canada.
Jazyk: angličtina
Zdroj: Inflammatory bowel diseases [Inflamm Bowel Dis] 2024 Jul 03; Vol. 30 (7), pp. 1211-1214.
DOI: 10.1093/ibd/izad168
Databáze: MEDLINE